Oragenics Announces New Trading Symbol "OGEN" and Trading of Shares on Both the OTCQB and OTCBB

Before you go, we thought you'd like these...
Before you go close icon

Oragenics Announces New Trading Symbol "OGEN" and Trading of Shares on Both the OTCQB and OTCBB

TAMPA, Fla.--(BUSINESS WIRE)-- Oragenics, Inc. (OTCQB: OGEN) (OTCBB: OGEN) (www.oragenics.com) today announced that its new trading symbol on the OTCBB is "OGEN". The Company's shares are also trading on the OTCQB, an inter-dealer quotation system for publicly traded companies that are current in their SEC required filings, and its OTCQB trading symbol has also changed to "OGEN".

"We believe the symbol change to "OGEN" better aligns our stock symbol with our brand name and while our shares trade on the OTCBB, the quotation of our shares on OTCQB remains a positive development because it provides access to the larger number of market makers and better trading platform that we believe the OTCQB provides," said Dr. John Bonfiglio, the Company's Chief Executive Officer. The OTCQB is owned by a private company, OTC Market Groups, Inc., which distinguishes its trading platform from the OTCBB on the basis of being more efficient by being an electronic trading platform rather than telephonic. Shareholders and potential investors can now obtain detailed trading information regarding the Company, including real-time bid and ask quotes, at http://www.otcmarkets.com/stock/OGEN/quote.


About Oragenics, Inc.

Oragenics, Inc. is focused on becoming the world leader in probiotics for oral health for humans and pets and in novel antibiotics against infectious disease. Oragenics, Inc. develops, markets and sells proprietary probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora in over 13 countries worldwide. Oragenics, Inc. has established an exclusive worldwide channel collaboration for lantibiotics, a novel class of broad spectrum antibiotics, with Intrexon Corporation, a synthetic biology company.

For more information, visit www.oragenics.com. Follow Oragenics on Facebook and Twitter.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX:OTCM) operates the world's largest Open, Transparent and Connected financial marketplace platform. Our OTC Link(R) ATS directly links a diverse network of broker-dealers that provide liquidity and execution services in almost 10,000 equity and debt securities. We organize these securities into marketplaces to inform investors of opportunities and risks - OTCQX(R) - The Intelligent Marketplace for the Best OTC Companies; OTCQB(R) - The Venture Marketplace; and OTC Pink(R) - The Open Marketplace. Our information and data-driven platform enables trading through any broker at the best possible price and empowers companies to improve the quality and availability of information for their investors. To learn more about how we create smarter financial marketplaces, visit www.otcmarkets.com.

Safe Harbor Statement: Under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements that reflect the Company's current views with respect to future events and financial performance. These forward-looking statements are based on management's beliefs and assumptions and information currently available. The words "believe," "expect," "anticipate," "intend," "estimate," "project" and similar expressions that do not relate solely to historical matters identify forward-looking statements. Investors should be cautious in relying on forward-looking statements because they are subject to a variety of risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed in any such forward-looking statements. These factors include those set forth in our most recently filed annual report on Form 10-K and quarterly report on Form 10-Q, and other factors detailed from time to time in filings with the U.S. Securities and Exchange Commission. We expressly disclaim any responsibility to update forward-looking statements.

For more information regarding Oragenics, contact:

 

Corporate Contact:

Michael Sullivan

Chief Financial Officer


Oragenics, Inc

3000 Bayport Drive, Suite 685

Tampa, Fl 33607

Tel: 813-286-7900 x246

Direct: 813-786-6431

msullivan@oragenics.com

Investor Contact:

Robert Giordano

President


LaunchPad IR

880 Third Avenue, 6th Floor

New York NY 10022

Tel: 1-800-625-2236 x7770

Direct: 917-327-3938

rgiordanonyc@gmail.com



Oragenics, Inc
Corporate Contact:
Michael Sullivan, 813-286-7900 x246
Chief Financial Officer
Direct: 813-786-6431
msullivan@oragenics.com
or
Investor Contact:
Robert Giordano, 1-800-625-2236 x7770
President
Direct: 917-327-3938
rgiordanonyc@gmail.com

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:

The article Oragenics Announces New Trading Symbol "OGEN" and Trading of Shares on Both the OTCQB and OTCBB originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners